rethinkPeptides Search
Menu
Research citation

Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial.

European journal of heart failure, 27(3), 540-551

Citation

Neves, João Sérgio; Leite, Ana Rita; Mentz, Robert J; Holman, Rury R; Zannad, Faiez; Butler, Javed; Packer, Milton; Ferreira, João Pedro. (2025). Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial.. European journal of heart failure, 27(3), 540-551. https://doi.org/10.1002/ejhf.3478